C. Gilks, S. Crowley, R. Ekpini, S. Gove, J. Perriens et al., The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings, The Lancet, vol.368, issue.9534, pp.505-515, 2006.
DOI : 10.1016/S0140-6736(06)69158-7

D. Moore, J. Mermin, A. Awor, B. Yip, R. Hogg et al., Performance of Immunologic Responses in Predicting Viral Load Suppression, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.4, pp.436-445, 2006.
DOI : 10.1097/01.qai.0000243105.80393.42

G. Bisson, R. Gross, J. Strom, C. Rollins, S. Bellamy et al., Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy, AIDS, vol.20, issue.12, pp.1613-1622, 2006.
DOI : 10.1097/01.aids.0000238407.00874.dc

J. Stringer, I. Zulu, J. Levy, E. Stringer, A. Mwango et al., Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia, JAMA, vol.296, issue.7, pp.782-93, 2006.
DOI : 10.1001/jama.296.7.782

K. Castetbon, X. Anglaret, S. Touré, G. Chêne, T. Ouassa et al., Prognostic Value of Cross-sectional Anthropometric Indices on Short-term Risk of Mortality in Human Immunodeficiency Virus-infected Adults in Abidjan, Cote d'Ivoire, American Journal of Epidemiology, vol.154, issue.1, pp.75-84, 2001.
DOI : 10.1093/aje/154.1.75

R. Zachariah, M. Fitzgerald, M. Massaquoi, O. Pasulani, L. Arnould et al., Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi, AIDS, vol.20, issue.18, pp.2355-60, 2006.
DOI : 10.1097/QAD.0b013e32801086b0

L. Ferradini, A. Jeannin, L. Pinoges, J. Izopet, D. Odhiambo et al., Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1377, 2006.
DOI : 10.1016/S0140-6736(06)68580-2

J. Etard, I. Ndiaye, M. Thierry-mieg, N. Gueye, P. Gueye et al., Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1190, 2006.
DOI : 10.1097/01.aids.0000226959.87471.01

M. Van-der-sande, S. Van-der-loeff, M. Aveika, A. Sabally, S. Togun et al., Body Mass Index at Time of HIV Diagnosis, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.37, issue.2, pp.1288-94, 2004.
DOI : 10.1097/01.qai.0000122708.59121.03

K. Castetbon, X. Anglaret, A. Attia, S. Toure, N. Dakoury-dogbo et al., Effect of early chemoprophylaxis with cotrimoxazole on nutritional status evolution in HIV-1 infected adults in Abidjan, Côte d'Ivoire, AIDS, vol.15, pp.869-876, 2001.

C. Danel, R. Moh, A. Minga, A. Anzian, O. Ba-gomis et al., CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial, The Lancet, vol.367, issue.9527, pp.1981-1989, 2006.
DOI : 10.1016/S0140-6736(06)68887-9

C. Danel, R. Moh, A. Anzian, Y. Abo, H. Chenal et al., Tolerance and Acceptability of an Efavirenz-Based Regimen in 740 Adults (Predominantly Women) in West Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, issue.1, pp.29-35, 2006.
DOI : 10.1097/01.qai.0000219777.04927.50

C. Danel, R. Moh, G. Peytavin, A. Anzian, A. Minga et al., Short Communication: Lack of Indinavir-Associated Nephrological Complications in HIV-Infected Adults (Predominantly Women) with High Indinavir Plasma Concentration in Abidjan, C??te d'Ivoire, AIDS Research and Human Retroviruses, vol.23, issue.1, pp.62-66, 2007.
DOI : 10.1089/aid.2006.0038

W. Who, Expert Consultation on Cotrimoxazole Prophylaxis in HIV Infection. WHO technical report series. Reference number: WHO/HIV, 2006.

F. Rouet, D. Ekouevi, M. Chaix, M. Burgard, A. Inwoley et al., Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005.
DOI : 10.1128/JCM.43.6.2709-2717.2005

D. Moore, R. Hogg, B. Yip, E. Wood, M. Tyndall et al., Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.40, issue.3, pp.288-93, 2005.
DOI : 10.1097/01.qai.0000182847.38098.d1

R. Kantor, R. Shafer, S. Follansbee, J. Taylor, D. Shilane et al., Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy, AIDS, vol.18, issue.11, pp.1503-1514, 2004.
DOI : 10.1097/01.aids.0000131358.29586.6b

J. Tassie, E. Szumilin, A. Calmy, and E. Goemaere, Highly active antiretroviral therapy in resource-poor settings, AIDS, vol.17, issue.13, pp.1995-2002, 2003.
DOI : 10.1097/00002030-200309050-00023

D. Coetzee, K. Hildebrand, A. Boulle, G. Maartens, F. Louis et al., Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa, AIDS, vol.18, issue.6, pp.887-95, 2004.
DOI : 10.1097/00002030-200404090-00006

P. Severe, P. Leger, M. Charles, F. Noel, G. Bonhomme et al., Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti, New England Journal of Medicine, vol.353, issue.22, pp.2325-2359, 2005.
DOI : 10.1056/NEJMoa051908

T. Toni, B. Masquelier, D. Bonard, M. Faure, C. Huet et al., Primary HIV-1 drug resistance in Abidjan (C??te d'Ivoire): a genotypic and phenotypic study, AIDS, vol.16, issue.3, pp.488-91, 2002.
DOI : 10.1097/00002030-200202150-00024

T. Toni, P. Recordon-pinson, A. Minga, D. Ekouevi, D. Bonard et al., Presence of Key Drug Resistance Mutations in Isolates from Untreated Patients of Abidjan, C??te d'Ivoire: ANRS 1257 Study, AIDS Research and Human Retroviruses, vol.19, issue.8, pp.713-720, 2003.
DOI : 10.1089/088922203322280946

M. Schechter and S. Tuboi, Discordant immunological and virological responses to antiretroviral therapy, Journal of Antimicrobial Chemotherapy, vol.58, issue.3, pp.506-516, 2006.
DOI : 10.1093/jac/dkl263
URL : http://jac.oxfordjournals.org/cgi/content/short/58/3/506